| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;100:2177.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
Cardiovascular Abnormalities in Transgenic Mice With Reduced Brown Fat
An Animal Model of Human Obesity
Presented in part at the 70th Scientific Sessions of the American Heart Association, Orlando, Fla, November 9–12, 1997, and published in abstract form (Circulation. 1997;96[suppl I]:I-465).
From the Charles A. Dana Research Institute and the Harvard-Thorndike Laboratory, Cardiovascular and Endocrinology (C.S.M., J.S.F.) Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Correspondence to Antonio Cittadini, MD, Department of Internal Medicine, Federico II Medical School, Via Sergio Pansini, 5 (Edificio 18), 80131 Naples, Italy. E-mail cittadin{at}unina.it
Background—A new model of murine obesity has recently been developed through transgenic ablation of brown adipose tissue that manifests typical metabolic complications of obesity, including insulin resistance and non–insulin-dependent diabetes mellitus. The cardiovascular phenotype has not been defined.
Methods and Results—Transthoracic echocardiography, aortic catheterization, isolated whole-heart studies, and morphometric histology defined cardiac structure and function in 30 transgenic mice with reduced brown fat and 30 matched wild-type controls. Obesity was indicated by a 77% increase in body weight and was accompanied by elevated systemic pressures (mean aortic blood pressure 85±1 versus 66±2 mm Hg; P<0.01), left ventricular dilation and hypertrophy (mass/body weight 4.0±0.2 versus 2.7±0.3 mg/g; P<0.01), and high cardiac output (cardiac index 3.2±0.4 versus 2.4±0.1 mL · kg-1 · min-1; P<0.01). Baseline functional parameters assessed in vitro were not different, but after imposition of zero-flow ischemia, significant relaxation impairment developed in obese mice. Although morphometrically determined myocyte diameters were similar, the percentage of interstitial fibrosis was significantly increased in transgenic mice compared with wild-type controls (7.5±2% versus 4.2±0.2%; P<0.01).
Conclusions—Transgenic ablation of brown adipose tissue is associated not only with obesity but also with systemic hypertension, left ventricular hypertrophy with eccentric remodeling and fibrosis, and high cardiac output, a unique constellation of findings strikingly similar to that seen in human obesity. Mice with reduced brown fat may serve as a new model for the cardiovascular morbid complications associated with obesity in humans.
Key Words: brown fat • hypertrophy • echocardiography
This article has been cited by other articles:
 |
|
 |
|
  E. D. Abel, S. E. Litwin, and G. Sweeney Cardiac Remodeling in Obesity Physiol Rev, April 1, 2008; 88(2): 389 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Boudina and E. D. Abel Diabetic Cardiomyopathy Revisited Circulation, June 26, 2007; 115(25): 3213 - 3223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Duncan, J. L. Fong, D. M. Medeiros, B. N. Finck, and D. P. Kelly Insulin-Resistant Heart Exhibits a Mitochondrial Biogenic Response Driven by the Peroxisome Proliferator-Activated Receptor-{alpha}/PGC-1{alpha} Gene Regulatory Pathway Circulation, February 20, 2007; 115(7): 909 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Tallam, D. E. Stec, M. A. Willis, A. A. da Silva, and J. E. Hall Melanocortin-4 Receptor-Deficient Mice Are Not Hypertensive or Salt-Sensitive Despite Obesity, Hyperinsulinemia, and Hyperleptinemia Hypertension, August 1, 2005; 46(2): 326 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Nadeau, L. C. Burrage, J. Restivo, Y.-H. Pao, G. Churchill, and B. D. Hoit Pleiotropy, Homeostasis, and Functional Networks Based on Assays of Cardiovascular Traits in Genetically Randomized Populations Genome Res., September 1, 2003; 13(9): 2082 - 2091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Barouch, D. E. Berkowitz, R. W. Harrison, C. P. O'Donnell, and J. M. Hare Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently of Body Weight in Mice Circulation, August 12, 2003; 108(6): 754 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Hu, D. Zhang, L. Swenson, G. Chakrabarti, E. D. Abel, and S. E. Litwin Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1261 - H1269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Algenstaedt, C. Schaefer, T. Biermann, A. Hamann, B. Schwarzloh, H. Greten, W. Ruther, and N. Hansen-Algenstaedt Microvascular Alterations in Diabetic Mice Correlate With Level of Hyperglycemia Diabetes, February 1, 2003; 52(2): 542 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Semeniuk, A. J. Kryski, and D. L. Severson Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H976 - H982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Valet, G. Tavernier, I. Castan-Laurell, J. S. Saulnier-Blache, and D. Langin Understanding adipose tissue development from transgenic animal models J. Lipid Res., June 1, 2002; 43(6): 835 - 860. [Abstract] [Full Text] [PDF]
|
|